Solubilized ubiquinol for preserving corneal function
Youssef W Naguib,Sanjib Saha,Jessica M Skeie,Timothy Acri,Kareem Ebeid,Somaya Abdel-Rahman,Sandeep Kesh,Gregory A Schmidt,Darryl Y Nishimura,Jeffrey A Banas,Min Zhu,Mark A Greiner,Aliasger K Salem,Youssef W. Naguib,Jessica M. Skeie,Somaya Abdel-rahman,Gregory A. Schmidt,Darryl Y. Nishimura,Jeffrey A. Banas,Mark A. Greiner,Aliasger K. Salem
DOI: https://doi.org/10.1016/j.biomaterials.2021.120842
IF: 14
2021-08-01
Biomaterials
Abstract:<p>Defective cellular metabolism, impaired mitochondrial function, and increased cell death are major problems that adversely affect donor tissues during <a class="topic-link" href="/topics/biochemistry-genetics-and-molecular-biology/cryopreservation">hypothermic preservation</a><span><span><span><span> prior to transplantation. These problems are thought to arise from accumulated reactive oxygen species (ROS) inside cells. <a class="topic-link" href="/topics/biochemistry-genetics-and-molecular-biology/oxidative-stress">Oxidative stress</a><span> acting on the cells of organs and tissues preserved in hypothermic conditions before surgery, as is the case for cornea transplantation, is thought to be a major reason behind cell death prior to surgery and decreased graft survival after transplantation. We have recently discovered that ubiquinol – the reduced and active form of <a class="topic-link" href="/topics/materials-science/coenzyme">coenzyme</a> Q10 and a powerful antioxidant – significantly enhances mitochondrial function and reduces apoptosis in human donor corneal endothelial cells. However, ubiquinol is highly lipophilic, underscoring the need for an aqueous-based formulation of this molecule. Herein, we report a highly dispersible and stable formulation comprising a complex of ubiquinol and gamma </span></span><a class="topic-link" href="/topics/biochemistry-genetics-and-molecular-biology/cyclodextrin">cyclodextrin</a> (γ-CD) for use in aqueous-phase ophthalmic products. Docking studies showed that γ-CD has the strongest </span><a class="topic-link" href="/topics/biochemistry-genetics-and-molecular-biology/binding-affinity">binding affinity</a><span> with ubiquinol compared to α- or β-CD. Complexed ubiquinol showed significantly higher stability compared to free ubiquinol in different aqueous ophthalmic products including Optisol-GS® corneal storage medium, balanced salt solution for intraocular irrigation, and topical Refresh® artificial tear eye drops. Greater ROS scavenging activity was noted in a cell model with high <a class="topic-link" href="/topics/biochemistry-genetics-and-molecular-biology/basal-metabolic-rate">basal metabolism</a> and ROS generation (A549) and in HCEC-B4G12 human corneal endothelial cells after treatment with ubiquinol/γ-CD compared to free ubiquinol. Furthermore, complexed ubiquinol was more effective at lowering ROS, and at far lower concentrations, compared to free ubiquinol. Complexed ubiquinol inhibited </span></span><a class="topic-link" href="/topics/biochemistry-genetics-and-molecular-biology/lipid-peroxidation">lipid peroxidation</a><span><span><span> and protected HCEC-B4G12 cells against erastin-induced <a class="topic-link" href="/topics/biochemistry-genetics-and-molecular-biology/ferroptosis">ferroptosis</a>. No evidence of cellular toxicity was detected in HCEC-B4G12 cells after treatment with complexed ubiquinol. Using a vertical diffusion system, a topically applied inclusion complex of γ-CD and a lipophilic dye (coumarin-6) demonstrated transcorneal </span><a class="topic-link" href="/topics/biochemistry-genetics-and-molecular-biology/penetrance">penetrance</a> in porcine corneas and the capacity for the γ-CD vehicle to deliver drug to the corneal endothelium. Using the same model, topically applied ubiquinol/γ-CD complex penetrated the entire thickness of human donor corneas with markedly greater ubiquinol retention in the endothelium compared to free ubiquinol. Lastly, the penetrance of ubiquinol/γ-CD complex was assayed using human donor corneas preserved for 7 days in Optisol-GS® per standard industry practices, and demonstrated higher amounts of ubiquinol retained in the corneal endothelium compared to free ubiquinol. In summary, ubiquinol complexed with γ-CD is a highly stable composition that can be incorporated into a variety of aqueous-phase products for ophthalmic use including donor corneal storage media and topical eye drops to scavenge ROS and protect corneal endothelial cells against </span><a class="topic-link" href="/topics/engineering/oxidative-damage">oxidative damage</a>.</span></span></p>
engineering, biomedical,materials science, biomaterials